BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37831314)

  • 21. Conversion of mammalian 3alpha-hydroxysteroid dehydrogenase to 20alpha-hydroxysteroid dehydrogenase using loop chimeras: changing specificity from androgens to progestins.
    Ma H; Penning TM
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11161-6. PubMed ID: 10500147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sebocytes are the key regulators of androgen homeostasis in human skin.
    Fritsch M; Orfanos CE; Zouboulis CC
    J Invest Dermatol; 2001 May; 116(5):793-800. PubMed ID: 11348472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of remote substrate binding energy to the enzymatic rate acceleration for 3α-hydroxysteroid dehydrogenase/carbonyl reductase.
    Hwang CC; Chang PR; Wang TP
    Chem Biol Interact; 2017 Oct; 276():133-140. PubMed ID: 28137513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Steroidogenic Metabolism of Galeterone Reveals a Diversity of Biochemical Activities.
    Alyamani M; Li Z; Berk M; Li J; Tang J; Upadhyay S; Auchus RJ; Sharifi N
    Cell Chem Biol; 2017 Jul; 24(7):825-832.e6. PubMed ID: 28648378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer.
    Li Z; Bishop AC; Alyamani M; Garcia JA; Dreicer R; Bunch D; Liu J; Upadhyay SK; Auchus RJ; Sharifi N
    Nature; 2015 Jul; 523(7560):347-51. PubMed ID: 26030522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of trough abiraterone level on adverse events in patients with prostate cancer treated with abiraterone acetate.
    Takahashi Y; Narita S; Shiota M; Miura M; Kagaya H; Kashima S; Yamamoto R; Nara T; Huang M; Numakura K; Saito M; Eto M; Habuchi T
    Eur J Clin Pharmacol; 2023 Jan; 79(1):89-98. PubMed ID: 36378297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic structure of rat 3alpha-hydroxysteroid/dihydrodiol dehydrogenase (3alpha-HSD/DD, AKR1C9).
    Lin HK; Hung CF; Moore M; Penning TM
    J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):29-39. PubMed ID: 10619355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abiraterone inhibits 3β-hydroxysteroid dehydrogenase: a rationale for increasing drug exposure in castration-resistant prostate cancer.
    Li R; Evaul K; Sharma KK; Chang KH; Yoshimoto J; Liu J; Auchus RJ; Sharifi N
    Clin Cancer Res; 2012 Jul; 18(13):3571-9. PubMed ID: 22753664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics of allopregnanolone formation catalyzed by human 3 alpha-hydroxysteroid dehydrogenase type III (AKR1C2).
    Trauger JW; Jiang A; Stearns BA; LoGrasso PV
    Biochemistry; 2002 Nov; 41(45):13451-9. PubMed ID: 12416991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focused metabolomics using liquid chromatography/electrospray ionization tandem mass spectrometry for analysis of urinary conjugated cholesterol metabolites from patients with Niemann-Pick disease type C and 3β-hydroxysteroid dehydrogenase deficiency.
    Maekawa M; Shimada M; Ohno K; Togawa M; Nittono H; Iida T; Hofmann AF; Goto J; Yamaguchi H; Mano N
    Ann Clin Biochem; 2015 Sep; 52(Pt 5):576-87. PubMed ID: 25575700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A quick UPLC-MS/MS method for therapeutic drug monitoring of abiraterone and delta(4)-abiraterone in human plasma.
    Weiss TLD; Furtado CM; Antunes MV; Gössling G; Schwartsmann G; Linden R; Verza SG
    Biomed Chromatogr; 2020 Nov; 34(11):e4947. PubMed ID: 32652651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgen formation and metabolism in the pulmonary epithelial cell line A549: expression of 17beta-hydroxysteroid dehydrogenase type 5 and 3alpha-hydroxysteroid dehydrogenase type 3.
    Provost PR; Blomquist CH; Godin C; Huang XF; Flamand N; Luu-The V; Nadeau D; Tremblay Y
    Endocrinology; 2000 Aug; 141(8):2786-94. PubMed ID: 10919264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells.
    Rizner TL; Lin HK; Peehl DM; Steckelbroeck S; Bauman DR; Penning TM
    Endocrinology; 2003 Jul; 144(7):2922-32. PubMed ID: 12810547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A highly sensitive LC-MS/MS method for the simultaneous quantitation of serum androstane-3α, 17β-diol and androstane-3β, 17β-diol in post-menopausal women.
    Ke Y; Dury A; Labrie F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Apr; 1113():30-36. PubMed ID: 30877984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavior of 3alpha- and 7alpha-hydroxysteroid dehydrogenases on chenodeoxycholate substituted Sepharose.
    Macdonald IA; Williams CN; Mahony DE
    Steroids; 1976 Jul; 28(1):25-30. PubMed ID: 960146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human 3-alpha hydroxysteroid dehydrogenase type 3 (3α-HSD3): the V54L mutation restricting the steroid alternative binding and enhancing the 20α-HSD activity.
    Zhang B; Zhu DW; Hu XJ; Zhou M; Shang P; Lin SX
    J Steroid Biochem Mol Biol; 2014 May; 141():135-43. PubMed ID: 24434280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-function relationships in 3alpha-hydroxysteroid dehydrogenases: a comparison of the rat and human isoforms.
    Penning TM; Jin Y; Heredia VV; Lewis M
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):247-55. PubMed ID: 12943710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-stereo-selective cytosolic human brain tissue 3-ketosteroid reductase is refractory to inhibition by AKR1C inhibitors.
    Steckelbroeck S; Lütjohann D; Bauman DR; Ludwig M; Friedl A; Hans VH; Penning TM; Klingmüller D
    Biochim Biophys Acta; 2010 Nov; 1801(11):1221-31. PubMed ID: 20673851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A-ring modified steroidal azoles retaining similar potent and slowly reversible CYP17A1 inhibition as abiraterone.
    Garrido M; Peng HM; Yoshimoto FK; Upadhyay SK; Bratoeff E; Auchus RJ
    J Steroid Biochem Mol Biol; 2014 Sep; 143():1-10. PubMed ID: 24508512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolite identification of bentysrepinine (Y101), a novel anti-HBV agent in rats using a five-step strategy based on a combined workflow with two different platforms of liquid chromatography-tandem mass spectrometry.
    Fan H; Hu Z; Li R; Dong S; Gu Y; Liu T; Si D; Liang G; Liu C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():118-128. PubMed ID: 27978466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.